Paper18596129
PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B and 3 others. Nephrol Dial Transplant, 2008. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis. Papers, record 18596129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18596129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Matrix | Major topic |
| Glomerulonephritis | Major topic |
| Phosphodiesterase 5 Inhibitors | Major topic |
| Thrombospondin 1 | Major topic |
| Transforming Growth Factor beta | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Biopsy | |
| Cell Proliferation | |
| Cyclic GMP | |
| Cyclic Nucleotide Phosphodiesterases, Type 5 | |
| Disease Models, Animal | |
| Imidazoles | |
| Mesangial Cells | |
| Phosphodiesterase Inhibitors | |
| Piperazines | |
| Rats | |
| Rats, Sprague-Dawley | |
| Smad2 Protein | |
| Smad3 Protein | |
| Sulfones | |
| Thy-1 Antigens | |
| Triazines | |
| Vardenafil Dihydrochloride |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42764856 | Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42764856 | PubMed |
| 41276898 | Sildenafil suppresses the activation of hypertrophic scar fibroblasts by promoting the KLF15-mediated inhibition of LOXL1 transcription. | Korean J Physiol Pharmacol | 2026 | https://conductscience.org/library/papers/41276898 | PubMed |
| 36684968 | Chronic liver diseases and erectile dysfunction. | Front Public Health | 2022 | https://conductscience.org/library/papers/36684968 | PubMed |
| 35814506 | Does Treatment of Erectile Dysfunction With PDE 5 Inhibitor Tadalafil Improve Quality of Life in Male Patients With Compensated Chronic Liver Disease? A Prospective Pilot Study. | J Clin Exp Hepatol | 2022 | https://conductscience.org/library/papers/35814506 | PubMed |
| 34944010 | Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib. | Cells | 2021 | https://conductscience.org/library/papers/34944010 | PubMed |
| 32365529 | Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review. | J Clin Med | 2020 | https://conductscience.org/library/papers/32365529 | PubMed |
| 30392076 | The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury. | Pediatr Nephrol | 2019 | https://conductscience.org/library/papers/30392076 | PubMed |
| 28712304 | Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer. | Antioxid Redox Signal | 2017 | https://conductscience.org/library/papers/28712304 | PubMed |
| 28660304 | Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination. | Naunyn Schmiedebergs Arch Pharmacol | 2017 | https://conductscience.org/library/papers/28660304 | PubMed |
| 26242375 | Phosphodiesterase type 5 inhibitors and kidney disease. | Int Urol Nephrol | 2015 | https://conductscience.org/library/papers/26242375 | PubMed |
| 25752605 | Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes. | J Biol Chem | 2015 | https://conductscience.org/library/papers/25752605 | PubMed |
| 24701562 | Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24701562 | PubMed |
| 23150749 | Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease. | Oxid Med Cell Longev | 2012 | https://conductscience.org/library/papers/23150749 | PubMed |
| 22874763 | Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management. | Am J Physiol Renal Physiol | 2012 | https://conductscience.org/library/papers/22874763 | PubMed |
| 21949402 | Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21949402 | PubMed |
| 21133896 | Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21133896 | PubMed |
| 20828589 | Mesangial pathology in glomerular disease: targets for therapeutic intervention. | Adv Drug Deliv Rev | 2010 | https://conductscience.org/library/papers/20828589 | PubMed |
| 20563733 | Phosphodiesterase-5 gene (PDE5A) polymorphisms are associated with progression of childhood IgA nephropathy. | Pediatr Nephrol | 2010 | https://conductscience.org/library/papers/20563733 | PubMed |
| 20212516 | Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy. | Nat Rev Urol | 2010 | https://conductscience.org/library/papers/20212516 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| THBS1 | 7057 | PubTator's text mining | https://conductscience.org/library/genes/7057 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18596129
GET https://conductscience.org/api/papers/v1/18596129/authors